Primary and secondary outcome
| Long-term DAPT (n=65) N (per 100 patient-years) | Short-term DAPT (n=68) N (per 100 patient-years) | HR (95% CI) | P value | |
| Primary outcome | ||||
| Ischemic stroke | 0 (0.0) | 1 (2.1) | 0.35 (0.002 to 6.54) | 0.328 |
| Secondary outcome | ||||
| Death or any stroke | 1 (2.2) | 1 (2.1) | 1.06 (0.09 to 13.0) | 0.969 |
| Hemorrhagic event | 2 (4.3) | 0 (0.0) | 3.35 (0.20 to 487.3) | 0.273 |
| Death, any stroke or hemorrhagic event | 2 (4.3) | 1 (2.1) | 1.17 (0.13 to 13.9) | 0.814 |
| Retreatment, stent occlusion/stenosis | 1 (2.2) | 3 (6.4) | 0.46 (0.04 to 2.81) | 0.355 |
The reference group is short-term DAPT group.
DAPT, dual antiplatelet therapy.